Cargando…
Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines
Carboplatin-based chemotherapy is the primary treatment option for the management of retinoblastoma, an intraocular malignant tumor observed in children. The aim of the present study was to establish carboplatin-resistant retinoblastoma cell lines to facilitate future research into the treatment of...
Autores principales: | Cho, Chang Sik, Jo, Dong Hyun, Kim, Jin Hyoung, Kim, Jeong Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589373/ https://www.ncbi.nlm.nih.gov/pubmed/36047446 http://dx.doi.org/10.14348/molcells.2022.2014 |
Ejemplares similares
-
Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012) -
Correction: Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012) -
STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters
por: Jo, Dong Hyun, et al.
Publicado: (2014) -
L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma
por: Jo, Dong Hyun, et al.
Publicado: (2017) -
Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy
por: Choi, Won Jong, et al.
Publicado: (2021)